Check-Cap (CHEK) investor relations material

Company overview and business model

• Operates as an embodied AI company, providing a hardware-agnostic orchestration platform for autonomous systems, primarily targeting the hospitality sector with multi-year, fixed-fee deployments per robot.

• Does not manufacture robots but procures them from third parties and deploys them with its software and services.

• Recently completed a merger, shifting from a clinical-stage medical diagnostics company to its current AI focus, retaining legacy medical assets and patents.

Financial performance and metrics

• Reported net income of $4.1 million for FY2025, compared to a net loss of $25.1 million in FY2024 (as adjusted for a 1-for-7 reverse share split).

• Weighted average ordinary shares outstanding (post-split) were 890,318 in FY2025 and 835,573 in FY2024.

• Cash and equivalents as of July 31, 2026, were $9.4 million (pro forma for recent offering and merger).

Use of proceeds and capital allocation

• Net proceeds from any primary offering will be used for general corporate purposes, including working capital, operating expenses, and R&D, with allocation depending on funding needs and capital availability.